Analysts expect Oragenics Inc to report revenue of 0.00 for Q4 22, against a range of 0.00 to 0.00. The most recent reported quarter, Q3 22, came in at 100,000.00.
| Metric | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 100,000.00 | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,624.80 | 5,543.88 | 4,756.04 | |||||||||||||||||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,644.26 | 4,861.70 | 4,219.32 | |||||||||||||||||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,134.53 | 5,202.79 | 4,487.68 |
Analysts expect Oragenics Inc to report earnings per share of -76.39 for Q4 22, against a range of -82.80 to -69.98. The most recent reported quarter, Q2 26, came in at -0.57, a 110.6% miss against the 5.40 consensus.
| Metric | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -90.00 | -54.00 | -54.00 | - | - | - | - | - | - | - | - | -3.65 | -3.10 | -1.96 | -1.04 | -0.51 | -0.57 | |||||||||||||||||||
| High Estimate | -35.11 | -69.07 | -78.25 | -69.98 | -85.65 | -91.06 | -81.83 | -81.74 | -15.04 | -1.14 | -2.01 | -5.81 | 4.59 | 1.15 | -0.21 | -3.38 | 5.79 | |||||||||||||||||||
| Low Estimate | -41.77 | -80.55 | -92.69 | -82.80 | -103.45 | -98.58 | -88.47 | -88.64 | -17.36 | -1.34 | -2.17 | -7.07 | 4.27 | 0.97 | -0.25 | -3.72 | 5.01 | |||||||||||||||||||
| Consensus Estimate | -38.44 | -74.81 | -85.47 | -76.39 | -94.55 | -94.82 | -85.15 | -85.19 | -16.20 | -1.24 | -2.09 | -6.44 | 4.43 | 1.06 | -0.23 | -3.55 | 5.40 |
Pull Wall Street consensus for Oragenics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=OGEN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "OGEN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=OGEN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();